Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study - PubMed (original) (raw)
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study
H Cortez-Pinto et al. JAMA. 1999.
Abstract
Context: The mechanisms that drive progression from fatty liver to steatohepatitis and cirrhosis are unknown. In animal models, obese mice with fatty livers are vulnerable to liver adenosine triphosphate (ATP) depletion and necrosis, suggesting that altered hepatic energy homeostasis may be involved.
Objective: To determine if patients with fatty liver disease exhibit impaired recovery from hepatic ATP depletion.
Design: Laboratory analysis of liver ATP stores monitored by nuclear magnetic resonance spectroscopy before and after transient hepatic ATP depletion was induced by fructose injection. The study was conducted between July 15 and August 30, 1998.
Setting: University hospital.
Patients: Eight consecutive adults with biopsy-proven nonalcoholic steatohepatitis and 7 healthy age- and sex-matched controls.
Main outcome measure: Level of ATP 1 hour after fructose infusion in patients vs controls.
Results: In patients, serum aminotransferase levels were increased (P = .02 vs controls); albumin and bilirubin values were normal and clinical evidence of portal hypertension was absent in both groups. However, 2 patients had moderate fibrosis and 1 had cirrhosis on liver biopsy. Mean serum glucose, cholesterol, and triglyceride levels were similar between groups but patients weighed significantly more than controls (P = .02). Liver ATP levels were similar in the 2 groups before fructose infusion and decreased similarly in both after fructose infusion (P = .01 vs initial ATP levels). However, controls replenished their hepatic ATP stores during the 1-hour follow-up period (P<.02 vs minimum ATP) but patients did not. Hence, patients' hepatic ATP levels were lower than those of controls at the end of the study (P = .04). Body mass index (BMI) correlated inversely with ATP recovery, even in controls (R = -0.768; P = .07). Although BMI was greater in patients than controls (P = .02) and correlated strongly with fatty liver and serum aminotransferase elevations, neither of the latter 2 parameters nor the histologic severity of fibrosis strongly predicted hepatic ATP recovery.
Conclusions: These data suggest that recovery from hepatic ATP depletion becomes progressively less efficient as body mass increases in healthy controls and is severely impaired in patients with obesity-related nonalcoholic steatohepatitis.
Similar articles
- Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals.
Nair S, P Chacko V, Arnold C, Diehl AM. Nair S, et al. Am J Gastroenterol. 2003 Feb;98(2):466-70. doi: 10.1111/j.1572-0241.2003.07221.x. Am J Gastroenterol. 2003. PMID: 12591070 - No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men.
Johnston RD, Stephenson MC, Crossland H, Cordon SM, Palcidi E, Cox EF, Taylor MA, Aithal GP, Macdonald IA. Johnston RD, et al. Gastroenterology. 2013 Nov;145(5):1016-1025.e2. doi: 10.1053/j.gastro.2013.07.012. Epub 2013 Jul 19. Gastroenterology. 2013. PMID: 23872500 Clinical Trial. - Investigating the effects of an oral fructose challenge on hepatic ATP reserves in healthy volunteers: A (31)P MRS study.
Bawden SJ, Stephenson MC, Ciampi E, Hunter K, Marciani L, Macdonald IA, Aithal GP, Morris PG, Gowland PA. Bawden SJ, et al. Clin Nutr. 2016 Jun;35(3):645-9. doi: 10.1016/j.clnu.2015.04.001. Epub 2015 Apr 14. Clin Nutr. 2016. PMID: 25935852 - Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P, Barkin JS. Hookman P, et al. Am J Gastroenterol. 2003 Sep;98(9):2093-7. doi: 10.1111/j.1572-0241.2003.07670.x. Am J Gastroenterol. 2003. PMID: 14499793 Review. - Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.
Koliaki C, Roden M. Koliaki C, et al. Mol Cell Endocrinol. 2013 Oct 15;379(1-2):35-42. doi: 10.1016/j.mce.2013.06.002. Epub 2013 Jun 12. Mol Cell Endocrinol. 2013. PMID: 23770462 Review.
Cited by
- Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD.
Moore MP, Shryack G, Alessi I, Wieschhaus N, Meers GM, Johnson SA, Wheeler AA, Ibdah JA, Parks EJ, Rector RS. Moore MP, et al. Am J Physiol Endocrinol Metab. 2024 Apr 1;326(4):E493-E502. doi: 10.1152/ajpendo.00336.2023. Epub 2024 Feb 21. Am J Physiol Endocrinol Metab. 2024. PMID: 38381399 - Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.
Lanaspa MA, Sanchez-Lozada LG, Cicerchi C, Li N, Roncal-Jimenez CA, Ishimoto T, Le M, Garcia GE, Thomas JB, Rivard CJ, Andres-Hernando A, Hunter B, Schreiner G, Rodriguez-Iturbe B, Sautin YY, Johnson RJ. Lanaspa MA, et al. PLoS One. 2012;7(10):e47948. doi: 10.1371/journal.pone.0047948. Epub 2012 Oct 24. PLoS One. 2012. PMID: 23112875 Free PMC article. - Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.
Norén B, Lundberg P, Ressner M, Wirell S, Almer S, Smedby O. Norén B, et al. Eur Radiol. 2005 Jan;15(1):148-57. doi: 10.1007/s00330-004-2434-x. Epub 2004 Sep 3. Eur Radiol. 2005. PMID: 15351899 - Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.
Fontes A, Alemany-Pagès M, Oliveira PJ, Ramalho-Santos J, Zischka H, Azul AM. Fontes A, et al. Int J Mol Sci. 2019 Aug 16;20(16):3987. doi: 10.3390/ijms20163987. Int J Mol Sci. 2019. PMID: 31426291 Free PMC article. Review. - High-Intensity Interval Training is Safe, Feasible and Efficacious in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial.
Keating SE, Croci I, Wallen MP, Cox ER, Thuzar M, Pham U, Mielke GI, Coombes JS, Macdonald GA, Hickman IJ. Keating SE, et al. Dig Dis Sci. 2023 May;68(5):2123-2139. doi: 10.1007/s10620-022-07779-z. Epub 2022 Dec 20. Dig Dis Sci. 2023. PMID: 36538276 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources